More frequently, the mutation occurs in the DNA binding domain, with the loss of function of the p53 tumor suppressor, despite some mutations being able to lead to gain-of-function through the binding of mutant p53 to other tumor suppressors such as p63 and p73 [71]. The gene discussed is TP53; the disease is neoplasm.